Sun Pharmaceutical Q2 FY27 Net Profit Falls 36% as US Formulation Sales Decline 8.2%
Sun Pharmaceutical Industries reported a consolidated net profit of ₹1,989 crore for the July‑September quarter (Q2 FY27), a decline of 36% from ₹3,118 crore logged in the same period last year. The d...